This Dutch AI Startup Just Raised $2 Million to Transform Hearing Care

·
Listen to this article~4 min

Clementine, a Dutch AI healthtech startup, has raised $2M in seed funding led by Healthy.Capital. Its platform uses an AI agent named Matthew to bridge the gap for the 1.5 billion people globally affected by hearing loss.

You know how the startup world is always buzzing about the next big thing in AI? Well, here's one that might actually make a real, tangible difference in people's lives. It's not just another chatbot—it's something built to tackle a silent global health crisis. A Maastricht-based startup called Clementine, or ClementineAI, just secured $2 million in Seed funding to scale its AI-powered hearing care platform. That's a significant vote of confidence for a company founded just this year. Healthy.Capital, an Amsterdam-based early-stage HealthTech investor, led the round. They've got a sharp eye for promising ventures, having previously backed companies like Pharmi and OpenUp. Their managing partner, Douwe Jippes, put it plainly: "Clementine combines deep domain expertise with a clear AI platform strategy that can scale globally. We believe this approach will fundamentally change how people with hearing disability engage with hearing healthcare." So, what's the big idea? Founder and CEO Vince van de Weijer started Clementine with a simple but powerful observation. He realized hearing clinics aren't really struggling for leads—they're struggling to have the right conversations at the right time. The result? A massive gap in care. ### The AI Agent Bridging the Care Gap At the heart of Clementine's platform is 'Matthew,' an AI hearing care agent. Think of Matthew as a compassionate, infinitely patient, and always-available first point of contact. This isn't a cold, robotic FAQ system. It's designed to engage directly with people who might be hesitant, scared, or just unsure about seeking help for hearing loss. Matthew works 24/7, answering questions without judgment and, crucially, without a waiting list. It educates users, helps them overcome both emotional and practical barriers, and gently guides them toward the appropriate next steps for care. For clinics, this means Matthew handles the initial, time-consuming administrative conversations, translating inquiries into actual bookings. For patients, it means a smoother, less intimidating path to better hearing. "Clinics don't need more leads; they need better conversations at the right moment," van de Weijer says. "Matthew ensures no patient inquiry goes unanswered." The scale of the problem Clementine is tackling is staggering. They point out that hearing loss affects roughly 1.5 billion people worldwide. Here's the kicker: nearly 80% of those people never seek treatment. And for the ones who finally do? They typically wait over eight years from when they first notice a problem. Eight years! That's a long time to miss out on conversations, connections, and clarity. ### Why This Funding Matters Now This seed investment didn't come out of nowhere. It follows closely on the heels of Clementine's strategic move to expand in North America. Just months ago, they partnered with Zoolstra, a marketing agency that works with hearing clinics and groups across the United States and Canada. That partnership gave them commercial footing, and this funding is the fuel to accelerate. The plan for the $2 million is straightforward but ambitious: - Deepen the core AI capabilities of the Matthew agent. - Expand partnerships with hearing clinics, optical retailers, and other healthcare organizations. It's a classic case of a startup finding product-market fit and then getting the resources to push harder. By blending AI with behavioral science, Clementine isn't just selling software to clinics. They're trying to rebuild the front door to hearing healthcare—making it more open, more welcoming, and available the moment someone has a question, day or night. For professionals watching the European startup and HealthTech scene, this is a deal worth noting. It's a reminder that some of the most impactful AI applications aren't in flashy consumer apps, but in solving slow-burn, systemic problems in essential industries like healthcare. Clementine's journey from Maastricht is just beginning, but with this funding and its unique approach, it's aiming to make a lot of noise in the best way possible.